Expression and structural properties of a chimeric protein based on the ectodomains of E1 and E2 hepatitis C virus envelope glycoproteins

Protein Expression and Purification

Volumn 71, Issue 2, 2010, Pages 123-131

  Tello, Daniel ^a   Rodríguez Rodríguez, Mar ^a   Yélamos, Belén ^a   Gómez Gutiérrez, Julián ^a   Ortega, Sara ^a   Pacheco, Beatriz ^a   Peterson, Darrell L ^b   Gavilanes, Francisco ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Baculovirus; E1; E2; Envelope protein; Glycosylation; Hepatitis C virus

Indexed keywords

GLYCOPROTEIN E2, HEPATITIS C VIRUS; HYBRID PROTEIN; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; VIRUS ENVELOPE PROTEIN;

ANIMAL; ARTICLE; BACULOVIRUS; GENETICS; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ANIMALS; ANTIBODIES, MONOCLONAL; BACULOVIRIDAE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEPACIVIRUS; HUMANS; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS; HEXAPODA;

EID: 77949487518     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2010.02.012     Document Type: Article

References (64)

1. Major M.E., Rehermann B., and Feinstone S.M. Hepatitis C viruses. In: Knipe D., and Howley P.M. (Eds). Fields Virology Lippincott (2001), Williams & Wilkins, Philadelphia 1
2. Lindenbach B.D., and Rice C.M. Flaviviridae: the viruses and their replication. In: Knipe D., and Howley P.M. (Eds). Fields Virology (2001), Lippincott Williams & Wilkins, Philadelphia 41
3. Feld J.J., and Hoofnagle J.H. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436 (2005) 967-972
4. Grakoui A., Wychowski C., Lin C., Feinstone S.M., and Rice C.M. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67 (1993) 1385-1395
5. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., and Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. USA 88 (1991) 5547-5551
6. Goffard A., and Dubuisson J. Glycosylation of hepatitis C virus envelope proteins. Biochimie 85 (2003) 295-301
7. Op De Beeck A., Cocquerel L., and Dubuisson J. Biogenesis of hepatitis C virus envelope glycoproteins. J. Gen. Virol. 82 (2001) 2589-2595
8. Helle F., and Dubuisson J. Hepatitis C virus entry into host cells. Cell Mol. Life Sci. 65 (2008) 100-112
9. Bartosch B., and Cosset F.L. Cell entry of hepatitis C virus. Virology 348 (2006) 1-12
10. Evans M.J., von Hahn T., Tscherne D.M., Syder A.J., Panis M., Woelk B., Hatziioannou T., McKeating J.A., Bieniasz P.D., and Rice C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446 (2007) 801-805
11. Bartosch B., Verney G., Dreux M., Donot P., Morice Y., Penin F., Pawlotsky J.M., Lavillette D., and Cosset F.L. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J. Virol. 79 (2005) 8217-8229
12. Habersetzer F., Fournillier A., Dubuisson J., Rosa D., Abrignani S., Wychowski C., Nakano I., Trépo C., Desgranges C., and Inchauspé G. Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties. Virology 249 (1998) 32-41
13. Zibert A., Kraas W., Ross R.S., Meisel H., Lechner S., Jung G., and Roggerdorf M. Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection. J. Hepatol. 30 (1999) 177-184
14. Shimizu Y.K., Igarashi H., Kiyohara T., Cabezon T., Farci P., Purcell R.H., and Yoshikura H. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 223 (1996) 409-412
15. Dreux M., Pietschmann T., Granier C., Voisset C., Ricard-Blum S., Mangeot P.E., Keck Z., Foung S., Vu-Dac N., Dubuisson J., Bartenschlager R., Lavillette D., and Cosset F.L. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. J. Biol. Chem. 281 (2006) 18285-18295
16. Keck Z.Y., Sung V.M.H., Perkins S., Rowe J., Paul S., Liang T.J., Lai M.M.C., and Foung S.K.H. Human monoclonal antibody to hepatitis C virus El glycoprotein that blocks virus attachment and viral infectivity. J. Virol. 78 (2004) 7257-7263
17. Pietschmann T., Kaul A., Koutsoudakis G., Shavinskaya A., Kallis S., Steinmann E., Abid K., Negro F., Dreux M., Cosset F.L., and Bartenschlager R. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. USA 103 (2006) 7408-7413
18. Bartosch B., Bukh J., Meunier J.C., Granier C., Engle R.E., Blackwelder W.C., Emerson S.U., Cosset F.L., and Purcell R.H. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc. Natl. Acad. Sci. USA 100 (2003) 14199-14204
19. Keck Z.Y., Op de Beeck A., Hadlock K.G., Xia J.M., Li T.K., Dubuisson J., and Foung S.K.H. Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions. J. Virol. 78 (2004) 9224-9232
20. Leroux-Roels G., DeLeys R., Stuyver L., Elewaut A., Philippé J., Desombere I., Paradijs J., and Maertens G. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa. Hepatology 23 (1996) 8-16
21. Bartosch B., Dubuisson J., and Cosset F.L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exper. Med. 197 (2003) 633-642
22. Hsu M., Zhang J., Flint M., Logvinoff C., Cheng-Mayer C., Rice C.M., and McKeating J.A. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. USA 100 (2003) 7271-7276
23. Zhong J., Gastaminza P., Cheng G.F., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102 (2005) 9294-9299
24. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 (2005) 791-796
25. Hüssy P., Faust H., Wagner J.-C., Schmid G., Mous J., and Jacobsen H. Evaluation of hepatitis C virus enveloped proteins expressed in E. coli and insect cells for use as tools for antibody screening. J. Hepatol. 26 (1997) 1179-1186
26. Mustilli A.C., Izzo E., Houghton M., and Galeotti C.L. Comparison of secretion of a hepatitis C virus glycoprotein in Saccharomyces cerevisiae and Kluyveromyces lactis. Res. Microbiol. 150 (1999) 179-187
27. Hüssy P., Schmid G., Mous J., and Jacobsen H. Purification and in vitro-phospholabeling of secretory envelope proteins E1 and E2 of hepatitis C virus expressed in insect cells. Virus Res. 45 (1996) 45-57
28. Michalak J.-P., Wychowski C., Choukhi A., Meunier J.-C., Ung S., Rice C.M., and Dubuisson J. Characterization of truncated forms of hepatitis C virus glycoproteins. J. Gen. Virol. 78 (1997) 2299-2306
29. Lorent E., Bierau H., Engelborghs Y., Verheyden G., and Bosman F. Structural characterisation of the hepatitis C envelope glycoprotein E1 ectodomain derived from a mammalian and a yeast expression system. Vaccine 26 (2008) 399-410
30. Rodriguez-Rodriguez M., Tello D., Yelamos B., Gomez-Gutierrez J., Pacheco B., Ortega S., Serrano A.G., Peterson D.L., and Gavilanes F. Structural properties of the ectodomain of hepatitis C virus E2 envelope protein. Virus Res. 139 (2009) 91-99
31. Sandrin V., Boulanger P., Penin F., Granier C., Cosset F.L., and Bartosch B. Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins. J. Gen. Virol. 86 (2005) 3189-3199
32. Op De Beeck A., Voisset C., Bartosch B., Ciczora Y., Cocquerel L., Keck Z., Foung S., Cosset F.L., and Dubuisson J. Characterization of functional hepatitis C virus envelope glycoproteins. J. Virol. 78 (2004) 2994-3002
33. Lambot M., Fretier S., De Beeck A.O., Quatannens B., Lestavel S., Clavey W., and Dubuisson J. Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment. J. Biol. Chem. 277 (2002) 20625-20630
34. Laemmli V.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
35. Perczel A., Hollósi M., Tusnády G., and Fasman G.D. Decovolution of the circular dichroism spectra of proteins: the circular dichroism spectra of antiparallel -sheet in proteins. Protein Eng. 4 (1991) 669-679
36. Garnier J., Gibrat J.-F., and Robson B. GOR method for predicting protein secondary structure from amino acid sequence. In: Doolittle R.F.E. (Ed). Methods in Enzimology vol. 266 (1996), Academic Press 540-553
37. Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78 (2000) 1606-1609
38. Swoboda I., Bugajska-Schretter A., Verdino P., Keller W., Sperr W.R., Valent P., Valenta R., and Spitzauer S. Recombinant carp parvalbumin, the major cross-reactive fish allergen: a tool for diagnosis and therapy of fish allergy. J. Immunol. 168 (2002) 4576-4584
39. Helle F., Goffard A., Morel V., Duverlie G., McKeating J., Keck Z.Y., Foung S., Penin F., Dubuisson J., and Voisset C. The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein. J. Virol. 81 (2007) 8101-8111
40. Hu Y.W., Rocheleau L., Larke B., Chui L., Lee B., Ma M., Liu S., Omlin T., Pelchat M., and Brown E.G. Immunoglobulin mimicry by hepatitis C virus envelope protein E2. Virology 332 (2005) 538-549
41. Choo Q.-L., Kuo G., Ralston R., Weiner A., Chien D., van Nest G., Han J., Berger K., Thudium K., Kuo C., Kansopon J., McFarland J., Tabrizi A., Ching K., Moss B., Cummins L.B., Houghton M., and Muchmore E. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. USA 91 (1994) 1294-1298
42. García J.E., Puentes A., Suárez J., López R., Vera R., Rodríguez L.E., Ocampo M., Curtidor H., Guzmán F., Urquiza M., and Patarroyo M.-E. Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells. J. Hep. 36 (2002) 254-262
43. Lagging L.M., Meyer K., Owens R.J., and Ray R. Functional role of hepatitis C virus chimeric glycoproteins in the effectivity of pseudotyped virus. J. Virol. 72 (1998) 3539-3546
44. Triyatni M., Saunier B., Maruvada P., Davis A.R., Ulianich L., Heller T., Patel A., Kohn L.D., and Liang T.J. Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. J. Virol. 76 (2002) 9335-9344
45. Baumert T.F., Ito S., Wong D.T., and fLiang T.J. Hepatitis C virus structural proteins assemble into virus like particles in insect cells. J. Virol. 72 (1998) 3827-3836
46. Tani H., Komoda Y., Matsuo E., Suzuki K., Hamamoto I., Yamashita T., Moriishi K., Fujiyama K., Kanto T., Hayashi N., Owsianka A., Patel A.H., Whitt M.A., and Matsuura Y. Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins. J. Virol. 81 (2007) 8601-8612
47. Yurkova M.S., Patel A.H., and Fedorov A.N. Characterisation of bacterially expressed structural protein E2 of hepatitis C virus. Protein Expresssion Purif. 37 (2004) 119-125
48. Owsianka A., Clayton R.F., Loomis-Price L.D., McKeating J.A., and Patel A.H. Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. J. Gen. Virol. 82 (2001) 1877-1883
49. Patel A.H., Wood J., Penin F., Dubuison J., and McKeating J.A. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding. J. Gen. Virol. 81 (2000) 2873-2883
50. Martinez-Donato G., Acosta-Rivero N., Morales-Grillo J., Musacchio A., Vina A., Alvarez C., Figueroa N., Guerra I., Garcia J., Varas L., Muzio V., and Duenas-Carrera S. Expression and processing of hepatitis C virus structural proteins in Pichia pastoris yeast. Biochem. Biophys. Res. Commun. 342 (2006) 625-631
51. Matsuo E., Tani H., Komoda Y., Okamoto T., Miyamoto H., Moriishi K., Yagi S., Patel A.H., Miyamura T., and Matsuura Y. Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus. Biochem. Biophys. Res. Commun. 340 (2006) 200-208
52. Xiang Z.H., Cai W.J., Zhao P., Kong L.B., Ye L.B., and Wu Z.H. Purification and application of bacterially expressed chimeric protein E1E2 of hepatitis C virus. Protein Expresssion Purif. 49 (2006) 95-101
53. Dubuisson J., and Rice C.M. Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin. J. Virol. 70 (1996) 778-786
54. Helenius A., and Aebi M. Intracellular functions of N-linked glycans. Science 291 (2001) 2364-2369
55. Goffard A., Callens N., Bartosch B., Wychowski C., Cosset F.L., Montpellier C., and Dubuisson J. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J. Virol. 79 (2005) 8400-8409
56. Dubuisson J., Hsu H.H., Cheung R.C., Greengberg H.C., Russell D.G., and Rice C.M. Formation and intracellular localization of hepatitis C virus enveloped glycoprotein complexes expressed by recombinant vaccinia and sindbis viruses. J. Virol. 68 (1994) 6148-6160
57. Ralston R., Thudium K., Berger K., Kuo C., Gervase B., Hall J., Selby M., Kuo G., Houghton M., and Choo Q.L. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J. Virol. 67 (1993) 6753-6761
58. Deleersnyder V., Pillez A., Wychowski C., Blight K., Xu J., Hahn Y.S., Rice C.M., and Dubuisson J. Formation of native hepatitis C virus glycoprotein complexes. J. Virol. 71 (1997) 697-704
59. Dubuisson J. Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. Curr. Top. Microbiol. Immunol. 242 (2000) 135-148
60. Seong Y.R., Lee C.-H., and Im D.-S. Characterization of the structural proteins of hepatitis C virus expressed by an adenovirus recombinant. Virus Res. 55 (1998) 177-185
61. Matsuura Y., Tani H., Suzuki K., Kimura-Someya T., Suzuki R., Aizaki H., Ishii K., Moriishi K., Robison C.S., Whitt M.A., and Miyamura T. Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286 (2001) 263-275
62. Meyer K., Beyene A., Bowlin T.L., Basu A., and Ray R. Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer. J. Virol. 78 (2004) 12838-12847
63. Brazzoli M., Helenius A., Foung S.K.H., Houghton M., Abrignani S., and Merola M. Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells. Virology 332 (2005) 438-453
64. Cocquerel L., Quinn E.R., Flint M., Hadlock K.G., Foung S.K.H., and Levy S. Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody. J. Virol. 77 (2003) 1604-1609